baicalin has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, RS; Deng, X; Han, B; Han, JJ; Hao, DX; Li, X; Qi, WH; Xing, K; Yang, YN; Zhang, Y | 1 |
| Dong, Y; Gao, Y; Guan, T; Li, M; Lv, P; Meng, N; Qi, Q; Teng, Z; Xiao, Y; Xu, J; Yang, X; Zhang, J | 1 |
2 other study(ies) available for baicalin and Demyelinating Diseases
| Article | Year |
|---|---|
Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Demyelinating Diseases; Disease Models, Animal; Flavonoids; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Skills Disorders; PPAR gamma; Remyelination; Signal Transduction | 2022 |
Baicalin facilitates remyelination and suppresses neuroinflammation in rats with chronic cerebral hypoperfusion by activating Wnt/β-catenin and inhibiting NF-κB signaling.
Topics: Animals; Anti-Inflammatory Agents; beta Catenin; Brain Ischemia; Dementia, Vascular; Demyelinating Diseases; Neuroinflammatory Diseases; NF-kappa B; Rats; Remyelination; Wnt Signaling Pathway | 2023 |